Document ID: chunk:federal_register_of_legislation:F2021L00353:reg:9:p1
Version: federal_register_of_legislation:F2021L00353
Segment Type: reg
Provision Reference: reg 9 (pt 1/2)
Character Range: 3599–6790

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, seborrhoeic dermatitis or death from seborrhoeic dermatitis is connected with the circumstances of a person's relevant service:
(1)          having infection with human immunodeficiency virus before the clinical onset of seborrhoeic dermatitis;
(2)          having Parkinson's disease or secondary parkinsonism at the time of the clinical onset of seborrhoeic dermatitis;
(3)          having a physical disability or psychiatric disease which significantly limits the person's ability to maintain personal hygiene of the affected area at the time of the clinical onset of seborrhoeic dermatitis;
            Note: Examples of conditions which can significantly limit a person's ability to maintain personal hygiene include severe injuries, paralysis, immobility, alcohol use disorder and major depressive disorder.
(4)          being immobile for at least the four weeks before the clinical onset of seborrhoeic dermatitis;
            Note: Examples of being immobile include being in intensive care, having a spinal cord injury and, for facial seborrhoeic dermatitis, having facial paralysis.
(5)          taking a drug from the specified list of drugs for the treatment of cancer or autoimmune disease for at least the seven days before the clinical onset of seborrhoeic dermatitis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(6)          taking a drug which is associated in the individual with the clinical onset of seborrhoeic dermatitis during drug therapy and either:
(a)           the improvement of seborrhoeic dermatitis within three months of discontinuing or tapering drug therapy; or
(b)          the redevelopment of seborrhoeic dermatitis on rechallenge with the same drug; and
where taking the drug continued for at least the seven days before the clinical onset of seborrhoeic dermatitis;
(7)          having infection with human immunodeficiency virus before the clinical worsening of seborrhoeic dermatitis;
(8)          having Parkinson's disease or secondary parkinsonism at the time of the clinical worsening of seborrhoeic dermatitis;
(9)          having a physical disability or psychiatric disease which significantly limits the person's ability to maintain personal hygiene of the affected area at the time of the clinical worsening of seborrhoeic dermatitis;
            Note: Examples of conditions which can significantly limit a person's ability to maintain personal hygiene include severe injuries, paralysis, immobility, alcohol use disorder and major depressive disorder.
(10)      being immobile for at least the four weeks before the clinical worsening of seborrhoeic dermatitis;
            Note: Examples of being immobile include being in intensive care, having a spinal cord injury and, for facial seborrhoeic dermatitis, having facial paralysis.
(11)      taking a drug from the specified list of drugs for the treatment of cancer or autoimmune disease for at least the seven days before the clinical worsening of seborrhoeic dermatitis;
Note: specified list of drugs is